Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy DOI
Zongquan Zhang, Xiaoya Liang, Xi Yang

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(6), С. 6689 - 6708

Опубликована: Фев. 1, 2024

Tumor development and metastasis are closely related to the complexity of metabolism network. Recently, reprogramming strategies have attracted much attention in tumor therapy. Although there is preliminary success therapy agents, their therapeutic effects been restricted by effective reaching sites drugs. Nanodelivery systems with unique physical properties elaborate designs can specifically deliver tumors. In this review, we first summarize research progress nanodelivery based on enhance therapies depleting glucose, inhibiting glycolysis, lactic acid, lipid metabolism, glutamine glutathione, disrupting metal metabolisms combined other therapies, including chemotherapy, radiotherapy, photodynamic therapy, etc. We further discuss detail advantages for As well as opportunities challenges integrating into analyze outlook these emerging areas. This review expected improve our understanding modulating enhanced

Язык: Английский

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies DOI Creative Commons
Qian Zhou,

Yu Meng,

Daishi Li

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Март 8, 2024

Ferroptosis is a non-apoptotic form of regulated cell death characterized by the lethal accumulation iron-dependent membrane-localized lipid peroxides. It acts as an innate tumor suppressor mechanism and participates in biological processes tumors. Intriguingly, mesenchymal dedifferentiated cancer cells, which are usually resistant to apoptosis traditional therapies, exquisitely vulnerable ferroptosis, further underscoring its potential treatment approach for cancers, especially refractory cancers. However, impact ferroptosis on extends beyond direct cytotoxic effect cells. induction not only inhibits but also promotes development due negative anticancer immunity. Thus, comprehensive understanding role crucial successful translation therapy from laboratory clinical applications. In this review, we provide overview recent advancements cancer, covering molecular mechanisms, functions, regulatory pathways, interactions with microenvironment. We summarize applications immunotherapy, radiotherapy, systemic therapy, well inhibition various conditions. finally discuss markers, current challenges future directions cancer.

Язык: Английский

Процитировано

141

Current advance of nanotechnology in diagnosis and treatment for malignant tumors DOI Creative Commons

Bilan Wang,

Shiqi Hu, Yan Teng

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Авг. 12, 2024

Cancer remains a significant risk to human health. Nanomedicine is new multidisciplinary field that garnering lot of interest and investigation. shows great potential for cancer diagnosis treatment. Specifically engineered nanoparticles can be employed as contrast agents in diagnostics enable high sensitivity high-resolution tumor detection by imaging examinations. Novel approaches labeling are also made possible the use nanoprobes nanobiosensors. The achievement targeted medication delivery therapy accomplished through rational design manufacture nanodrug carriers. Nanoparticles have capability effectively transport medications or gene fragments tissues via passive active targeting processes, thus enhancing treatment outcomes while minimizing harm healthy tissues. Simultaneously, context radiation sensitization photothermal enhance therapeutic efficacy malignant tumors. This review presents literature overview summary how nanotechnology used According oncological diseases originating from different systems body combining pathophysiological features cancers at sites, we most recent developments applications. Finally, briefly discuss prospects challenges cancer.

Язык: Английский

Процитировано

79

Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions DOI Creative Commons

Peilin Lu,

Dongxue Ruan,

Meiqi Huang

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2024, Номер 9(1)

Опубликована: Июль 1, 2024

The applications of hydrogels have expanded significantly due to their versatile, highly tunable properties and breakthroughs in biomaterial technologies. In this review, we cover the major achievements potential therapeutic applications, focusing primarily on two areas: emerging cell-based therapies promising non-cell modalities. Within context cell therapy, discuss capacity overcome existing translational challenges faced by mainstream therapy paradigms, provide a detailed discussion advantages principal design considerations for boosting efficacy as well list specific examples different disease scenarios. We then explore drug delivery, physical intervention therapies, other areas (e.g., bioadhesives, artificial tissues, biosensors), emphasizing utility beyond mere delivery vehicles. Additionally, complement our latest progress clinical application outline future research directions, particularly terms integration with advanced biomanufacturing This review aims present comprehensive view critical insights into selection both tailored meet requirements diverse diseases situations.

Язык: Английский

Процитировано

78

Oxygen‐driven cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy DOI Creative Commons
Pei Pei,

Yuhong Wang,

Wenhao Shen

и другие.

Aggregate, Год журнала: 2024, Номер 5(3)

Опубликована: Янв. 4, 2024

Abstract The immunological implications of cuproptosis, a form cell death highly sensitive to oxygen presence, remain largely unexplored in the context tumor immunotherapy. Herein, we initially investigate positive correlation between cuproptosis and immunotherapy through bioinformatics analysis. Subsequently, an generator loaded with copper ions ( Cu/AP H‐M) has been constructed, which serves as effective carrier crucially enhances oxygenation microenvironment. Importantly, H‐M‐mediated dual strengthening radiotherapy could not only trigger powerful antitumor immunity related immunogenic by RNA‐sequencing analysis, but also effectively inhibit growth both distal situ low rectal tumors after combined immunotherapy, creating robust immune memory effect. Our work reveals beneficial effects enhanced radio‐immunotherapy elucidates its underlying mechanisms, provides novel approach for synergistic integration radiotherapy, broadening scope cuproptosis‐mediated therapy.

Язык: Английский

Процитировано

29

Hallmarks of cancer resistance DOI Creative Commons
Muhammad Tufail,

Jia-Ju Hu,

Jie Liang

и другие.

iScience, Год журнала: 2024, Номер 27(6), С. 109979 - 109979

Опубликована: Май 15, 2024

This review explores the hallmarks of cancer resistance, including drug efflux mediated by ATP-binding cassette (ABC) transporters, metabolic reprogramming characterized Warburg effect, and dynamic interplay between cells mitochondria. The role stem (CSCs) in treatment resistance regulatory influence non-coding RNAs, such as long RNAs (lncRNAs), microRNAs (miRNAs), circular (circRNAs), are studied. chapter emphasizes future directions, encompassing advancements immunotherapy, strategies to counter adaptive integration artificial intelligence for predictive modeling, identification biomarkers personalized treatment. comprehensive exploration these provides a foundation innovative therapeutic approaches, aiming navigate complex landscape enhance patient outcomes.

Язык: Английский

Процитировано

18

Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy DOI

Wei Xu,

Guoqiang Guan, Renye Yue

и другие.

Chemical Reviews, Год журнала: 2025, Номер unknown

Опубликована: Фев. 14, 2025

Ferroptosis, an iron-dependent form of regulatory cell death, has garnered significant interest as a therapeutic target in cancer treatment due to its distinct characteristics, including lipid peroxide generation and redox imbalance. However, clinical application oncology is currently limited by issues such suboptimal efficacy potential off-target effects. The advent nanotechnology provided new way for overcoming these challenges through the development activatable magnetic nanoparticles (MNPs). These innovative MNPs are designed improve specificity ferroptosis induction. This Review delves into chemical biological principles guiding design ferroptosis-based therapies imaging-guided therapies. It discusses mechanisms attributes ferroptosis, composition MNPs, their mechanism action inducers, integration with advanced imaging techniques monitoring. Additionally, we examine convergence other strategies, chemodynamic therapy, photothermal photodynamic sonodynamic immunotherapy, within context nanomedicine strategies utilizing MNPs. highlights multifunctional surpass limitations conventional treatments, envisioning future drug-resistance-free, precision diagnostics treating recalcitrant cancers.

Язык: Английский

Процитировано

4

New insight in immunotherapy and combine therapy in colorectal cancer DOI Creative Commons
Kai Ji,

Hang Jia,

Zixuan Liu

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2025, Номер 12

Опубликована: Янв. 7, 2025

The advent of immune checkpoint inhibitors (ICIs) in colorectal cancer (CRC) treatment marks a major breakthrough. These therapies have proven safer and more effective than traditional radiotherapy targeted treatments. Immunotherapies like pembrolizumab, nivolumab, ipilimumab pioneered new avenues, potentially improving patient outcomes quality life. Additionally, advances immunotherapy prompted detailed research into CRC therapies, especially those integrating ICIs with conventional treatments, providing hope for patients shaping future practice. This review delves the mechanisms various evaluates their therapeutic potential when combined radiotherapy, chemotherapy, clinical settings. It also sheds light on current application involving treatment.

Язык: Английский

Процитировано

2

GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells DOI Creative Commons
Min Lin, Yan Mo, Chengmin Li

и другие.

Medical Oncology, Год журнала: 2025, Номер 42(2)

Опубликована: Янв. 18, 2025

Язык: Английский

Процитировано

2

Recent Advances in Peptide Inhibitors Targeting Wild-Type Ras Protein Interactions in Cancer Therapy DOI Open Access
Weirong Qin, Zijian Liu,

Mingyu Huang

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(4), С. 1425 - 1425

Опубликована: Фев. 8, 2025

Ras proteins are pivotal in the regulation of cell proliferation signals, and their dysregulation is intricately linked to pathogenesis various malignancies. Peptide inhibitors hold distinct advantages targeting proteins, attributable extensive binding domains, which result from smooth surfaces proteins. The array specific strategies includes employment full hydrocarbon chains, cyclic peptides, linear N-terminal nucleation polypeptides. These methods effectively suppress signaling pathway through mechanisms, highlighting potential as anti-neoplastic agents. Moreover, cutting-edge methodologies, including aspartate strategy utilization hydrocarbon-stapled transforming landscape therapeutics aimed at innovations highlight promise peptide libraries combinatorial chemistry augmenting affinity, specificity, cellular permeability, for development potent anti-cancer incorporation dual therapeutic strategies, such synergy between conventional chemotherapy or use radiotherapy enhancers, emerges a compelling bolster efficacy cancer treatments Ras-MAPK pathway. Furthermore, recent studies have demonstrated that Ras-targeting stabilized peptides can amplify radio-sensitivity cells, offering an innovative approach enhance radiation therapy within management.

Язык: Английский

Процитировано

2

“Reinforcement” by Tumor Microenvironment: The Seventh “R” of Radiobiology DOI
Farzad Taghizadeh‐Hesary

International Journal of Radiation Oncology*Biology*Physics, Год журнала: 2023, Номер 119(3), С. 727 - 733

Опубликована: Ноя. 29, 2023

Язык: Английский

Процитировано

26